欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0405/001
药品名称Tilmovet solution for injection
活性成分
    • tilmicosin 300.0 mg/ml
剂型Solution for injection
上市许可持有人Huvepharma NV. Uitbreidingstraat 80, 2600 Antwerp, Belgium
参考成员国 - 产品名称Ireland (IE)
Tilmovet 300 mg/ml solution for injection
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Tilmovet 300 mg/ml
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
      TILMOVET 300 MG/ML SOLUTION INJECTABLE POUR BOVINS ET OVINS
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
    • Bulgaria (BG)
许可日期2019/03/13
最近更新日期2023/03/31
药物ATC编码
    • QJ01FA91 tilmicosin
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase